Mark J. Friedman

Mark J. Friedman is a declared insider at 2 companies; the most frequent names are Herbalife Ltd. and Niagen Bioscience, Inc. We count 10 filings; the first trade dates from 7 August 2014 and the latest from 17 May 2018.

Every open-market trade on record is a purchase: 2 purchases worth €17k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 4 option exercises. So far in 2018, the count stands at 1 purchase and no sales.

The record was last updated on 17 May 2018 with an open-market purchase (€9,156) in Niagen Bioscience, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.